Related Experiment Videos
m-Calpain (calcium-activated neutral proteinase) in Alzheimer's disease brains
T Tsuji1, S Shimohama, J Kimura
1Department of Neurology, Faculty of Medicine, Kyoto University, Japan.
Abstract:
An antibody specific for the calpain isoform m-calpain was used to resolve conflicting results from several studies on the possible role of m-calpain in the pathogenesis of Alzheimer's disease (AD). Levels of the enzyme in both cytosolic and membranous fractions of brain tissue were determined by Western blot analysis. We also demonstrated changes in m-calpain molecules in AD brains using high-resolution 2D gel electrophoresis (2DE). The levels of the m-calpain isoform detected in the cytosolic fraction were significantly increased in AD brains when compared with the levels in controls. On 2DE, m-calpain molecules resolved into eight main spots. These spots were detected in AD brains as well as in control brains, suggesting that the calpain molecule was not qualitatively changed in AD. Quantitative analysis of the m-calpain spots on 2DE, on the other hand, indicated that the ratio of the intensity of four protein spots in the acidic region to that of the total spots was increased in AD brains.
Insights
Researchers investigated m-calpain, a protein linked to Alzheimer's disease (AD), finding increased levels in the cytosolic fraction of AD brains. While the protein structure remained unchanged, its distribution shifted, suggesting a role in AD pathogenesis.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Alzheimer's disease (AD) pathogenesis involves complex molecular changes.
- Conflicting studies exist regarding the role of calpain isoforms, specifically m-calpain, in AD.
- Understanding m-calpain's specific role requires precise detection and quantification methods.
Purpose of the Study:
- To investigate the role of the m-calpain isoform in Alzheimer's disease pathogenesis.
- To quantify m-calpain levels in different cellular fractions of Alzheimer's disease brains.
- To analyze qualitative and quantitative changes in m-calpain molecules in Alzheimer's disease.
Main Methods:
- Western blot analysis to determine m-calpain levels in cytosolic and membranous brain fractions.
- High-resolution 2D gel electrophoresis (2DE) to analyze m-calpain molecular changes.
- Comparative analysis between Alzheimer's disease brains and control brains.
Main Results:
- Significantly increased levels of m-calpain were detected in the cytosolic fraction of Alzheimer's disease brains compared to controls.
- High-resolution 2DE revealed no qualitative changes in m-calpain molecules between Alzheimer's disease and control brains.
- Quantitative 2DE analysis showed an increased ratio of acidic m-calpain spots in Alzheimer's disease brains, indicating altered protein distribution.
Conclusions:
- M-calpain levels are elevated in the cytosolic fraction of Alzheimer's disease brains.
- While the m-calpain molecule itself is not qualitatively altered, its distribution is modified in Alzheimer's disease.
- These findings suggest a potential role for altered m-calpain distribution in the pathogenesis of Alzheimer's disease.